OSTEUM Trademark
Trademark Overview
On Monday, February 24, 1975, a trademark application was filed for OSTEUM with the United States Patent and Trademark Office. The USPTO has given the OSTEUM trademark a serial number of 73045056. The federal status of this trademark filing is EXPIRED as of Tuesday, July 23, 1996. This trademark is owned by SCHERING CORPORATION. The OSTEUM trademark is filed in the Pharmaceutical Products category with the following description:
OSTEOGENIC FORMULATION FOR THE STIMULATION OF FIBROUS AND FIBROCARTILAGENOUS TISSUE INTENDED FOR THE HEALING OF BONE DAMAGE IN ANIMALS
General Information
Serial Number | 73045056 |
Word Mark | OSTEUM |
Filing Date | Monday, February 24, 1975 |
Status | 900 - EXPIRED |
Status Date | Tuesday, July 23, 1996 |
Registration Number | 1022475 |
Registration Date | Tuesday, October 14, 1975 |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | OSTEOGENIC FORMULATION FOR THE STIMULATION OF FIBROUS AND FIBROCARTILAGENOUS TISSUE INTENDED FOR THE HEALING OF BONE DAMAGE IN ANIMALS |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 018 |
Class Status Code | 9 - Expired |
Class Status Date | Tuesday, July 23, 1996 |
Primary Code | 005 |
First Use Anywhere Date | Tuesday, December 17, 1974 |
First Use In Commerce Date | Tuesday, December 17, 1974 |
Trademark Owner History
Party Name | SCHERING CORPORATION |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | KENILWORTH, NJ 07033 |
Trademark Events
Event Date | Event Description |
Tuesday, July 23, 1996 | EXPIRED SEC. 9 |
Tuesday, April 21, 1981 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |